Timothy R. Church Ph.D. » Faculty

Biostatistics EnHS EpiCH HPM

Timothy R. Church Ph.D.

Professor

School of Public HealthDivision of Environmental Health Sciences

Address 420 Delaware Street SE 1162 Mayo MMC 807 Minneapolis MN 55455 United States Work Phone: 612-626-1494
Photo of  Timothy R. Church Ph.D.

Biography

Tim Church earned an M.S. and Ph.D. from the University of Minnesota. He conducts research on mass screening for cancer and other chronic diseases, and identification and treatment of cardiac arrhythmia with implantable devices. He is currently conducting the National Lung Screening Trial; the Prostate, Lung, Ovarian, and Prostate Cancer Screening Trial; the pilot study for the National Colonoscopy Trial; a study of risk factors for prostate cancer; two trials of chemoprevention of polyps; a study of familial colon cancer; and a study of colorectal cancer screening promotion. He teaches Occupational Epidemiology and a doctoral seminar on causal inference.

  • University of Minnesota, Doctor of Philosophy, Biostatistics, August 1984.
  • University of Minnesota, Master of Science, Biometry and Health Information Systems, March 1979.
  • Augustana College, Bachelor of Arts, Mathematics, June 1974.
  • Shattuck School, Faribault, Minnesota, Secondary School, June 1968.

Expertise:

Biostatistics, Cancer, Cancer: Screening, Cardiovascular Disease, Causal Inference, Clinical Research, Clinical Trials, Community-Based Research, Diagnostic Testing & Medical Imaging, Environmental Health, Epidemiology, Injuries / Injury Prevention, Research Methods, Screening, Screening: Cancer, Screening: Cardiovascular Disease

Professional Experience:

  • July 2005- present, Professor, Division of Environmental Health Sciences, School of Public Health, University of Minnesota.
  • July 1996-June 2005, Associate Professor, Division of Environmental Health Sciences, School of Public Health, University of Minnesota.
  • Oct 1993-July 1996, Director, Tachyarrhythmia Clinical Studies Center, Tachyarrhythmia Management Business, Medtronic, Inc.
  • May 1992-July 1996, Senior Research Associate, Environmental and Occupational Health, School of Public Health, University of Minnesota.
  • Jan 1987-May 1992, Research Associate, Environmental and Occupational Health, School of Public Health, University of Minnesota.
  • July 1982-Jan 1987, Manager of Biometry, Clinical Operations Department, Medtronic, Inc.
  • July 1980-July 1982, Biometrician, Biometry Group, Clinical Operations Department, Medtronic, Inc.
  • July 1978-July 1980, Research Fellow, Division of Biometry, University of Minnesota.
  • July 1974-July 1980, Statistical and Data Processing Analyst, Department of Graduate Studies in Pharmacy Administration, University of Minnesota.
  • January 1976-July 1980, Data Processing Consultant, Curriculum Management Information System of the Office of Student Affairs, College of Pharmacy, University of Minnesota.
  • February 1974-July 1974, Teaching Assistant, Department of Mathematics, Augustana College.

Honors:

  • Delta Omega Public Health Honorary Society, 1984.
  • Sigma Xi Honor Society, 1980.
  • Arthur B. Cohn Scholarship for Outstanding Freshmen, Rice University, 1968.
  • American Mathematics Association Award, 1967 and 1968.
  • Cum Laude, 1968.
  • Renssalaer Polytechnic Institute Award for Mathematics and Science, 1967.

Full CV

Research Interests:

Design, management, and analysis of clinical trials and environmental and occupational epidemiological studies, especially in the areas of screening for and prevention and etiology of cancer and cardiovascular disease; methods to incorporate model uncertainty into epidemiologic studies, mathematical representations of causal models, adjusting treatment effects for compliance in clinical trials, predictive probabilities for sudden cardiac death, and bias in observational studies of screening.

Selected Publications:

  • Shebl FM, Sakoda LC, Black A, Koshiol J, Andriole GL, Grubb R, Church TR, Chia D, Zhou C, Chu LW, Huang WY, Peters U, Kirsh VA, Chatterjee N, Leitzmann MF, Hayes RB, Hsing AW. “Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study.”British Journal of Cancer. 2012 Jun 26;107(1):207-14. Epub 2012 Jun 21.
  • Taylor KL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, Davis KM, Dawson DL, Edmond SN, Reding D, Mabie JE, Riley TL. “Long-term disease-specific functioning among prostate cancer survivors and non-cancer controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).” Journal of Clinical Oncology. 2012 Jun 25. [Epub ahead of print].
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O’Brien B, CarrickDM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team. “Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.” New England Journal of Medicine. 2012 Jun 21;366(25):2345-57. Epub 2012 May 21.
  • Olsen GW, Lange CC, Ellefson ME, Mair DC, Church TR, Goldberg CL, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Reagen WK, Zobel LR. “Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010.”Environmental Science & Technology. 2012 Jun 5;46(11):6330-8. Epub 2012 May 11.
  • Fang G, Haznadar M, Wang W, Yu H, Steinbach M, Church TR, Oetting WS, Van Ness B, Kumar V. “High-order SNP combinations associated with complex diseases: efficient discovery, statistical power and functional interactions.” PLoS One. 2012;7(4):e33531. Epub 2012 Apr 19. PMCID: PMC3334940.
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC. “Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.” Gastrointestinal Endoscopy. 2012 Mar;75(3):612-20.
  • Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD. PLCO Project Team. “Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.” Journal of the National Cancer Institute. 104(4):280-9, 2012 Feb 22.
  • Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC, for the PLCO Project Team. “Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.” Journal of the National Cancer Institute. 2012 Jan 18;104(2):125-132. Epub 2012 Jan 6. PMCID: PMC3260132 [Available on 2013/1/18]
  • Flammang D, Church TR, De Roy L, Blanc JJ, Leroy J, Mairesse GH, Otmani A, Graux PJ, Frank R, Purnode P; ATP Multicenter Study. “Treatment of unexplained syncope: A multicenter, randomized trial of cardiac pacing guided by adenosine 5′-triphosphate testing.” Circulation. 2012 Jan 3;125(1):31-6. Epub 2011 Nov 15.
  • Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR. “Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.” Molecular Carcinogenesis. 2012 Jan;51(1):128-37.
  • Nachreiner NM, Gerberich SG, Ryan AD, Erkal S, McGovern PM, Church TR, Mongin SJ, Feda DM. “Risk of physical assault against school educators with histories of occupational and other violence: A case-control study.” Work. 2012 Jan 1;42(1):39-46.
  • Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD; PLCO Project Team. “Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.” Journal of the American Medical Association. 2011 Nov 2;306(17):1865-73. Epub 2011 Oct 26.
  • Olsen GW, Ellefson ME, Mair DC, Church TR, Goldberg CL, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Reagen WK, Zobel LR. “Analysis of a homologous series of perfluorocarboxylates from American Red Cross adult blood donors, 2000-2001 and 2006.”Environmental Science and Technology. 2011 Oct 1;45(19):8022-9. Epub 2011 Apr 29.
  • Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD for The National Lung Screening Trial Research Team. “Reduced lung-cancer mortality with low-dose computed tomographic screening.” New England Journal of Medicine. 2011 Aug 4;365(5):395-409. Epub 2011 Jun 29.
    National Lung Screening Trial Research Team / National Lung Screening Trial Executive Committee: Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin JG, Gohagan JK, Hillman B, Jacobs PM, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Tatum JL, Zylak CJ
  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC. “Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation.” Journal of the National Cancer Institute. 2011 Jul 6;103(13):1058-68. Epub 2011 May 23.
  • Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O’Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team. “Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.” Journal of the American Medical Association. 2011 Jun 8;305(22):2295-303.
  • Olsen GW, Ellefson ME, Mair DC, Church TR, Goldberg CL, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Reagen WK, Zobel LR. “Analysis of a homologous series of perfluorocarboxylates from American Red Cross adult blood donors, 2000-2001 and 2006.”Environmental Science and Technology. 2011 Apr 29. [Epub ahead of print]
  • Gerberich SG, Nachreiner NM, Ryan AD, Church TR, McGovern PM, Geisser MS, Mongin SJ, Watt GD, Feda DM, Sage SK, Pinder ED. “Violence against educators: a population-based study.”Journal of Occupational and Environmental Medicine. 2011 Mar;53(3):294-302.
  • Shaukat A, Grau Sepulveda M, Church TR, Baxter G, Barry E, Summers RW, and Baron JA. “Serum salicylate levels and risk of recurrent of colorectal adenomas.” Cancer Epidemiology, Biomarkers & Prevention. 2011 Apr;20(4):679-82. Epub 2011 Feb 9.
  • Aberle DR, Berg   CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, and Zylak CJ. “The National Lung Screening Trial: overview and study design.”Radiology. 2011 Jan;258(1):243-53. Epub 2010 Nov 2.
  • National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF. “Baseline characteristics of participants in the randomized National Lung Screening Trial.” Journal of the National Cancer Institute. 2010 Dec 1;102(23):1771-9. Epub 2010 Nov 22. PubMed Central ID (PMCID): PMC2994863
    Collaborators (87): Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch DA, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ, Berg CD, Aberle DR, Fagerstrom RM, Gatsonis C, Gareen IF, Marcus PM, Cagnon C, Cody D, Fletcher G, Flynn MJ, Judy PF, Kruger R, Larke FJ, McNitt-Gray M, Payne T, Seibert JA, Wu X, Abbott G, Aberle DR, Amorosa JK, Barr RG, Black WC, Boiselle PM, Chiles C, Clark R, Coppage L, Falk R, Fishman EK, Gemmel D, Goldin JG, Goodman E, Hart EM, Hazelton T, Johnson E, Judy PF, Kazerooni E, McComb B, McLennan G, Munden RF, Ravenel J, Sullivan M, Swensen SJ, Torigian DA, Vydareny KH, Worrell JA, Balkin P, Church TR, Fouad M, Freedman MT, Garg K, Gelmann EP, Gierada DS, Hocking W, Inampudi S, Isaacs C, Kvale P, Lynch D, Mann H, Manor W, Nath H, Reding D, Spizarny DL, Strollo DC, Waltz J, Chen MH, Izmirilian G, Pinsky P, Prorok PC.
  • Church TR, Haznadar M, Geisser MS, Anderson KE, Caporaso NE, Le C, Abdullah S, Hecht SS, Oken M, Van Ness B.  (August 2010, Epub Date) “Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk.” International Journal of Molecular Epidemiology and Genetics, 1(4):295-309. PMCID: PMC3076775
  • Church TR, Anderson KE, Le C, Zhang Y, Kampa DM, Benoit AR, Yoder AR, Carmella SG, Hecht SS. (June 2010) “Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.” Biomarkers, 15(4):345–52. PMCID: PMC2871960
  • Williams QL Jr., Alexander BH, Gerberich SG, Nachreiner NM, Church TR, Ryan A. (Feb 2010) “Bystander injury evaluation of children from midwestern agricultural operations.” Journal of Safety Research, 41(1):31–37.
  • Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Reding DJ, Hayes RB, Church T, Yurgalevich S, Doria-Rose VP, Hickey T, Riley T, Berg CD. (Jan 2010) “Utilization of surveillance colonoscopy in community practice.” Gastroenterology, 138(1):73–81.
  • Carlson KF, Gerberich SG, Alexander BH, Masten AS, Church TR, Shutske JM, Ryan AD, Renier CM. (2009) “Children’s behavioral traits and  risk of injury: Analyses from a case-control study of agricultural households.” Journal of Safety Research, 40(2):97–103
  • Grubb RL 3rd, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg, CD, Crawford ED, Church TR, Andriole Jr GL, for the PLCO Project Team. (2009) “Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.” Cancer Epidemiology, Biomarkers and Prevention,18(3):748–51
  • Oaks BM, Dodd KW, Meinhold CL, Jiao L, Church TR, Stolzenberg-Solomon RZ. “Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.” American Journal of Clinical Nutrition,2010 February; 91(2): 449–455. PMCID: PMC2806895
  • Sage SK, Gerberich SG, Ryan AD, Nachreiner NM, Church TR, Alexander BH, Mongin SJ. (Jan 2010) “School resources, resource allocation, and risk of physical assault against Minnesota educators.” Accident Analysis & Prevention, 42(1):1–9.
  • Williams QL, Alexander BH, Gerberich SG, Nachreiner NM, Church TR, Ryan A. (Jan 2010) “Child bystanding: A risk factor for injury and identifying its’ determinants on midwestern agricultural operations.” Accident Analysis & Prevention, 42(1):10–18.
  • Shaukat A, Oancea C, Bond JH, Church TR,Allen JI. (2009) “Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program.”Clinical Gastroenterology and Hepatology, 7(12):1335–40.
  • Lundin JI, Alexander BH, Olsen GW, Church TR. (2009) “Ammonium perfluorooctanoate production and occupational mortality.” Epidemiology,20(6):921–28
  • Larson-Bright M, Gerberich SG, Masten AS, Alexander BH, Gurney JG, Church TR, Ryan AD, Renier CM. (2009) “Parents’ safety beliefs and childhood agricultural injury.”  American Journal of Industrial Medicine, 52(9):724–33.
  • Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE. “Cumulative incidence of false-positive results in repeated, multimodal cancer screening.” Annals of Family Medicine, 2009 May; 7(3): 212–222. PMCID: PMC2682972
  • Andriole GL, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, Crawford ED, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; for the PLCO Project Team. “Mortality results from a randomized prostate-cancer screening trial.”New England Journal of Medicine, 2009 March 26; 360(13): 1310–1319. PMCID: PMC2944770
  • Partridge E, Kreimer AR, Greenlee RT, Williams C, Xu JL, Church TR, Kessel B, Johnson CC, Weissfeld JL, Isaacs C, Andriole GL, Ogden S, Ragard LR, Buys SS; for the PLCO Project Team. “Results from four rounds of ovarian cancer screening in a randomized trial.” Obstetrics and Gynecology, 2009 April; 113(4): 775–782. PMCID: PMC272806
  • Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER. (2009) “A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.” Gastroenterology, 136(3):832–41.
  • Pinsky PF, Schoen RE, Weissfeld JL, Church TR, Yokochi LA, Doria-Rose VP, Prorok P. (2009) “The yield of surveillance colonoscopy by adenoma history and time to examination.” Clinical Gastroenterology and Hepatology, 7(1):86–92.
  • Church TR, Anderson KA, Caporaso N, Geisser MS, Le C, Zhang Y, Benoit A, Carmella S, Hecht SS. (2009) “A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.” Cancer Epidemiology, Biomarkers and Prevention,18(1):260–66.
  • Grubb RL 3rd, Pinsky PF, Greenlee RT, Izmirlian G, Miller AB, Hickey TP, Riley TL, Mabie JE, Levin DL, Chia D, Kramer BS, Reding DJ, Church TR, Yokochi LA, Kvale PA, Weissfeld JL, Urban DA, Buys SS, Gelmann EP, Ragard LR, Crawford ED, Prorok PC, Gohagan JK, Berg CD, Andriole GL, for the PLCO Project Team. (2008) “Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Update on findings from the initial four rounds of screening in a randomized trial.” British Journal of Urology International, 102(11):1524–30.
  • Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, Herron RM, Medhdizadekashi Z, Nobiletti JB,  Rios JA, Butenhoff JL, Zobel LR. (2008) “Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000–2006.” Environmental Science & Technology, 42(13):4989–95.
  • Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; for the Polyp Prevention Group. (2007) “Folic acid for the prevention of colorectal adenomas – A randomized clinical trial.” Journal of the American Medical Association,297(21):2351–59.
  • Bailey JJ, Hodges M, Church TR. (2007) “Decision to implant a cardioverter-defibrillator after myocardial infarction: The role of ejection fraction v. other risk factor markers.” Medical Decision Making,27(2):151–160.
  • Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD. (2007) “Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.” American Journal of Epidemiology, 165(8):874–81.
  • Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. (2008) “Validity of four self-reported colorectal cancer screening modalities in a general population: Differences over time and by intervention assignment.” Cancer Epidemiology Biomarkers and Prevention, 17(4):777–84.
  • Gierada DS, Pilgram TK, Ford M, Fagerstrom RM, Church TR, Nath H, Garg K, Strollo DC. (2008)  “Lung Cancer: Interobserver agreement on interpretation of pulmonary findings at low-dose CT screening.” Radiology, 246(1):265–72.
  • Larson-Bright M, Gerberich SG, Alexander BH, Gurney JG, Masten AS, Church TR, Ryan AD, Renier CM. “Work practices and childhood agricultural injury.” Injury Prevention, 2007 December; 13(6): 409–415. PMCID: PMC2598295
  • Tammemagi CM, Freedman MT, Church TR, Oken MM, Hocking WG, Kvale PAHu P, Riley TL, Ragard LR, Prorok PC, Berg CD. (2007) “Factors associated with human small aggressive non-small cell lung cancer.” Cancer Epidemiology, Biomarkers and Prevention,16(10):2082–89.
  • Nachreiner NM, Hansen HE, Okano A, Gerberich SG, Ryan AD, McGovern PM, Church TR, Watt GD. (2007) “Difference in work-related violence related to nurse license type.” Journal of Professional Nursing, 23(5):290–300.
  • Jurek AM, Maldonado G, Greenland S, Church TR. (2007) “Uncertainty analysis: An example of its application to estimating survey proportion.” Journal of Epidemiology and Community Health, 2007 July; 61(7): 650–654. PMCID: PMC2465740
  • Berndt SI, Huang W-Y, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB. (2007) “Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma.” Cancer Research,67(3):1395–1404.
  • Grau MV, Baron JA, Sandler RS, Wallace K, Haile RW, Church TR, Beck GJ, Summers RW, Barry EL, Cole BF, Snover D, Rothstein R, Mandel JS. (2007) “Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.” Journal of the National Cancer Institute, 99(2):129–136.
  • Greaves IA, Sexton K, Blumenthal MN, Church TR, Adgate JL, Ramachandran G, Fredrickson AL, Ryan AD, Geisser MS. (2007) “Asthma, atopy, and lung function among racially diverse, poor inner-urban Minneapolis schoolchildren.” Environmental Research,103(1):257–66.
  • Jurek AM, Maldonado G, Greenland S, Church TR. (2006) “Exposure-measurement error is frequently ignored when interpreting epidemiologic study results.” European Journal of Epidemiology,21(12):871–76.
  • Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS. (2006) “Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes and Control, 17:1299–1304.
  • Flood AP, Peters U, Jenkins D, Chatterjee N, Subar AF, Church TR, Bresalier R, Weissfeld JL, Hayes RB, Schatzkin A; for the PLCO Project Team. (2006) “Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study.” American Journal of Clinical Nutrition 84(5):1184–92.
  • Moslehi R, Chatterjee N, Church TR, Chen J, Yeager M, Weissfeld J, Hein DW, Hayes RB. (2006) “Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.”Pharmacogenomics 7(6):819–29.
  • Peters U, Chatterjee N, Church TR, Mayo C, Stürup S, Foster CB, Schatzkin A, Hayes RB. (2006) “High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal early detection program.” Cancer Epidemiology, Biomarkers and Prevention, 15(2):315–20.
  • Ramachandran G, Adgate, JL, Banerjee S, Church TR, Jones D, Fredrickson A, Sexton K. (2005) “Indoor air quality in two urban elementary schools – Measurements of airborne fungi, carpet allergens, CO(2), temperature, and relative humidity.” Journal of Occupational and Environmental Hygiene, 2(11):553–66.
  • Nachreiner NM, Gerberich SG, McGovern PM, Church TR, Hansen HE, Geisser MS, Ryan AD. (2005) “Relation between policies and work related assault: Minnesota Nurses’ Study.”Occupational and Environmental Medicine, 62(10):675–81.
  • Gerberich SG, Church TR, McGovern PM, Hansen HD, Nachreiner NM, Geisser M, Ryan AD, Mongin SJ, Jurek A. “Risk factors for work-related assaults on nurses.” Epidemiology, 2005 Sep;16(5):704-9.